Navigation Links
Caltech researchers get first 3-D glimpse of bacterial cell-wall architecture
Date:11/17/2008

PASADENA, Calif.--The bacterial cell wall that is the target of potent antibiotics such as penicillin is actually made up of a thin single layer of carbohydrate chains, linked together by peptides, which wrap around the bacterium like a belt around a person, according to research conducted by scientists at the California Institute of Technology (Caltech). This first-ever glimpse of the cell-wall structure in three dimensions was made possible by new high-tech microscopy techniques that enabled the scientists to visualize these biological structures at nanometer scales.

"This is both a technological and biological advance," says Grant Jensen, associate professor of biology at Caltech, a Howard Hughes Medical Institute investigator, and the principal investigator on the study.

Their research appears in the online early edition of the Proceedings of the National Academy of Sciences (PNAS).

"Bacterial cells rely on a cage-like net that surrounds them to maintain their integrity," Jensen explains. "If it weren't for this molecular bag, the bacteria couldn't survive; they would likely rupture."

This bag, called a sacculus, is made out of peptidoglycan, a mesh-like structure of carbohydrates (glycans) and amino-acid peptides. It is the sacculus, Jensen notes, that is targeted by the antibiotic penicillin; penicillin blocks a bacterium's ability to grow and remodel the bag to fit it as the bacterium itself grows. "If the bug can't make this bag," Jensen says, "it can't multiply, and you get better."

Researchers have long been interested in understanding the precise architecture of the sacculus. In particular, Jensen and his colleagues have wondered whether the so-called glycan strands--which are cross-linked by peptides to create peptidoglycan--"wrap around the cell like a belt wraps around a person," or whether they stand up from the surface of the bacterial cell, "like grass."

The answer to this debate has eluded the scientists, however, because trying to image such tiny biological objects has been beyond their technological reach. Until now, that is.

"Six years ago, a gift from the Moore Foundation allowed us to buy what is arguably the world's best electron cryomicroscope," says Jensen. "This allowed us to take a different kind of picture of small biological objects than has ever been possible before. These pictures are 3-D images to molecular resolution--you can actually start to see individual biological molecules. Using it, we were able to see this network of glycan strands. It was just remarkable."

By pairing the electron cryotomography and a purification technique that involved removing the sacculi and flattening them in a very thin layer of water, postdoctoral scholar Lu Gan, the paper's first author, was able to image the peptidoglycan structure in three dimensions, which allows for a virtual 3-D tour of the bacterial sacculus.

"What we saw were long skinny tubes wrapping around the bag like the ribs of a person or a belt around the waist," says Jensen. "We also saw that the sacculus is just a single layer thick."

"This is a clear answer to this old question," adds Gan. "We now know what the architecture of this most basic shape-determining molecule is. We now know the right answer versus having a family of answers, some of which are wrong."

Understanding how the cell wall is built is important, says Jensen, because scientists have long been in the dark about some of the most basic physical and mechanical aspects of bacterial life, including why they are shaped the way they are. "It's hard to understand how a building is constructed unless you can see the studs," he explains. "Now that we can see the studs--now that we can see the basic architecture of the sacculus--we're closer to understanding how a bacterium could direct its own growth, and how drugs that block that process might work."


'/>"/>

Contact: Lori Oliwenstein
lorio@caltech.edu
626-395-3631
California Institute of Technology
Source:Eurekalert

Related biology news :

1. UNC, Caltech research finds further evidence for genetic contribution to autism
2. Caltech researchers find dual-use sexual attraction and population-control chemicals in nematodes
3. Caltech scientists awarded $20 million to Power the Planet
4. Caltech neurobiologists discover individuals who hear movement
5. Caltech engineers build mini drug-producing biofactories in yeast
6. Caltech researchers awarded $10M for molecular programming project
7. Caltech scientists create DNA tubes with programmable sizes for nanoscale manufacturing
8. Caltech biologists spy on the secret inner life of a cell
9. Caltech scientists engineer supersensitive receptor, gain better understanding of dopamine system
10. Caltech engineers build firast-ever multi-input plug-and-play synthetic RNA device
11. Caltech geobiologists discover unique magnetic death star fossil
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/11/2017)... , Apr. 11, 2017 Research and Markets ... 2017-2021" report to their offering. ... The global eye tracking market to grow at a CAGR ... Global Eye Tracking Market 2017-2021, has been prepared based on an ... the market landscape and its growth prospects over the coming years. ...
(Date:4/5/2017)... April 5, 2017  The Allen Institute for Cell ... Explorer: a one-of-a-kind portal and dynamic digital window into ... data, the first application of deep learning to create ... cell lines and a growing suite of powerful tools. ... these and future publicly available resources created and shared ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
Breaking Biology News(10 mins):
(Date:4/20/2017)... - Prometic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF) ("Prometic" or ... Congress ("ILC") 2017 of the European Association for the Study ... on the positive effects of PBI-4050 on reduction of non-alcoholic ... syndrome. ... Lyne Gagnon, Vice-President of R&D Pre-clinical of Prometic "This extensive ...
(Date:4/20/2017)... ... ... Parallel6™ , the leader in mClinical™ technologies for improving patient enrollment, ... of the 2017 Top 10 eClinical Trial Management Solution Providers by Pharma Tech ... take pride in honoring Parallel6 as one of the top 10 companies that are ...
(Date:4/20/2017)... -- Dutch philosopher Koert van Mensvoort - founder of the ... Technology in Eindhoven - has written a ,Letter to Humanity, in ... to avoid becoming a slave and victim to its own technology, but to ... ... Koert van Mensvoort – founder of the Next Nature Network and Fellow of ...
(Date:4/20/2017)... For today, Stock-Callers.com redirects investors, attention ... and clinical research aimed at treating diseases and medical conditions. ... Biopharmaceuticals Inc. (NASDAQ: KERX), Kite Pharma Inc. (NASDAQ: KITE), and ... access our complimentary research reports on these stocks now at: ... http://stock-callers.com/registration ...
Breaking Biology Technology: